EUTM file information

018525959

LEQSELVI


August 1, 2021

Trademark Summary

The trademark application LEQSELVI was filed by Concert Pharmaceuticals, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on September 5, 2021, and it was registered by office on December 14, 2021 without any oppositions.

The application was filed in English (German was selected as the second language).


Goods And Services

  • The mark was filed in class 5 with following description of goods:
    1. Pharmaceutical preparations except for cardiovascular diseases
    2. Pharmaceutical preparations for the treatment of autoimmune, gastrointestinal, and inflammatory diseases and disorders
    3. Pharmaceutical preparations for the treatment of skin disorders
    4. Pharmaceutical preparations for the treatment of hair loss disorders
    5. Pharmaceutical preparations, namely, medicated dermatological preparations
    6. Pharmaceutical preparations for the treatment of alopecia areata, atopic dermatitis, vitiligo, irritable bowel disease, ulcerative colitis, Crohn's disease and rheumatoid arthritis.
Trademarkers